Back To Search Instructions
Protocols
7 protocols meet the specified criteria
Disease Site: Lung
Protocol No.TitleStatus
1300000502The Effect of Intermittent versus Continuous Dose Aspirin (ASA) on Nasal Epithelium Gene Expression in Current Smokers.Open
1300000683S1206: A Dose Finding Study Followed by Phase II Randomized, Placebo-Controlled Study of Veliparib (ABT-888) Added to Chemoradiotherapy with Carboplatin and Paclitaxel for Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC), (NCI Study Number 8811)Open
1403269898Clinical study of the effect of combined treatment of aspirin and zileuton on biomarkers of tobacco-related carcinogenesis in current smokers Open
1408439554A Phase II Randomized Study of Short-Term Dexamethasone Versus Placebo in Patients Receiving Radiation Alone or Radiation and Chemotherapy for the Treatment of Head and Neck and Non-Small Cell Lung CancersOpen
1412588451RANDOMIZED PHASE II TRIAL OF CONCURRENT CHEMORADIOTHERAPY +/- METFORMIN HCL IN LOCALLY ADVANCED NSCLC (NRG-LU001)Open
1504822040S1400: Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung CancerOpen
22129Assessment of functional brain changes by FOG-PET Brain Evaluation (FPBE) in cancer patients treated with systemic anticancer therapy.Open